These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 23442774)

  • 61. Compensatory expression of MRP3 in the livers of MRP2-deficient EHBRs is promoted by DHA intake.
    Kubo K; Sekine S; Saito M
    Biosci Biotechnol Biochem; 2009 Nov; 73(11):2432-8. PubMed ID: 19897918
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gd-EOB-DTPA-enhanced magnetic resonance imaging for bile duct intraductal papillary mucinous neoplasms.
    Ying SH; Teng XD; Wang ZM; Wang QD; Zhao YL; Chen F; Xiao WB
    World J Gastroenterol; 2015 Jul; 21(25):7824-33. PubMed ID: 26167082
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Unenhanced fat fraction ratios obtained by MR and enhanced T2* values with liver-specific MR contrast agents for diagnosis of non-alcoholic steatohepatitis in rats.
    Okada M; Katsube T; Kumano S; Kagawa Y; Araki T; Tsuda N; Okuaki T; Imaoka I; Tanigawa N; Ishii K; Murakami T
    Acta Radiol; 2011 Jul; 52(6):658-64. PubMed ID: 21498305
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of lapatinib on hepatic parenchymal enhancement on gadoxetate disodium (EOB)-enhanced MRI scans of the rat liver.
    Nakamura Y; Hirokawa Y; Kitamura S; Yamasaki W; Arihiro K; Tatsugami F; Iida M; Kakizawa H; Date S; Awai K
    Jpn J Radiol; 2013 Jun; 31(6):386-92. PubMed ID: 23605127
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.
    Kukuk GM; Schaefer SG; Fimmers R; Hadizadeh DR; Ezziddin S; Spengler U; Schild HH; Willinek WA
    Eur Radiol; 2014 Oct; 24(10):2482-90. PubMed ID: 25030459
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hypointense hepatocellular nodules on hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI: can increasing the flip angle improve conspicuity of lesions?
    Tamada T; Ito K; Yamamoto A; Yasokawa K; Higaki A; Kanki A; Sato T; Tanimoto D; Higashi H
    J Magn Reson Imaging; 2013 May; 37(5):1093-9. PubMed ID: 23148032
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?
    Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():87-93. PubMed ID: 20616589
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.
    Erstad DJ; Ramsay IA; Jordan VC; Sojoodi M; Fuchs BC; Tanabe KK; Caravan P; Gale EM
    Invest Radiol; 2019 Nov; 54(11):697-703. PubMed ID: 31356382
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis.
    Kim HY; Choi JY; Park CH; Song MJ; Song DS; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE
    J Gastroenterol; 2013 Oct; 48(10):1180-7. PubMed ID: 23354621
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
    Motosugi U; Ichikawa T; Sou H; Sano K; Ichikawa S; Tominaga L; Araki T
    J Magn Reson Imaging; 2009 Oct; 30(4):849-54. PubMed ID: 19787734
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Application of Diffusion-Weighted Imaging and Hepatobiliary-Specific Contrast Agent Gd-EOB-DTPA in the Diagnosis and Differential Diagnosis of Focal Liver Lesions].
    Chen GY; Li ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):737-743. PubMed ID: 36224672
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Non-invasive detection of biliary leaks using Gd-EOB-DTPA-enhanced MR cholangiography: comparison with T2-weighted MR cholangiography.
    Kantarcı M; Pirimoglu B; Karabulut N; Bayraktutan U; Ogul H; Ozturk G; Aydinli B; Kizrak Y; Eren S; Yilmaz S
    Eur Radiol; 2013 Oct; 23(10):2713-22. PubMed ID: 23695221
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
    Mühler A; Clément O; Vexler V; Berthezène Y; Rosenau W; Brasch RC
    Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional magnetic resonance cholangiography with Gd-EOB-DTPA: a study in healthy volunteers.
    Lee SW; Cha SH; Chung HH; Kim KH; Yeom SK; Seo BK; Je BK; Kim BH
    Magn Reson Imaging; 2014 May; 32(4):385-91. PubMed ID: 24529920
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
    Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
    J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of type 2 diabetes on Gd-EOB-DTPA uptake into liver parenchyma: replication study in human subjects.
    Kumasaka S; Seki Y; Kumasaka Y; Tsushima Y
    Abdom Radiol (NY); 2021 Oct; 46(10):4682-4688. PubMed ID: 34164726
    [TBL] [Abstract][Full Text] [Related]  

  • 80. "Speckled Enhancement" on Gd-EOB-DTPA Enhanced MR Imaging of Primary Hepatic Mucosa-associated Lymphoid Tissue Lymphoma.
    Hyodo R; Takehara Y; Nishida A; Matsushima M; Naganawa S
    Magn Reson Med Sci; 2023 Jul; 22(3):273-281. PubMed ID: 34615837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.